Background
==========

It is well known that high blood pressure is an important risk factor for cardiovascular diseases. Elevated blood pressure is a complicated trait that affects more than 30% of the adult population \[[@B1],[@B2]\]. An increase in systolic and diastolic blood pressure has a continuous impact on the risk of cardiovascular diseases. Globally, every year, high blood pressure contributes to approximately 13.5% of premature deaths, 54% of stroke, and 47% of ischemic heart disease \[[@B1],[@B3]\]. Genetic heritance is one of the major risk factors for hypertension. For complex diseases, the common disease-common variant (CD-CV) hypothesis that underpins genome-wide association studies (GWAS) has led to the identification of several novel susceptibility loci. However, a majority of the heritability is unexplained. It has been pointed out that the GWAS-identified variants can only explain a small portion of the heritability; therefore, exploration is still needed to unveil the undiscovered variants \[[@B12]\]. Recently, arguments have been put forward against CD-CV, and common disease-rare variants (CD-RV) as an alternative has been proposed. It is based on the assumption that the etiology for common diseases is caused by the cumulative effect of multiple rare variants \[[@B4],[@B5]\]. Nevertheless, another merging hypothesis states that common diseases are caused by the combination of common and rare variants \[[@B6]-[@B8]\].

In this paper, we focused on identifying whether a gene is associated with blood pressure. We applied recently proposed tests called \"test for testing the effect of an optimally weighted combination of variants (TOW)\" and \"variable weight-TOW (VW-TOW)\" \[[@B9]\] to determine significant genetic regions. Our interest also lies on identifying the associated variants for regions that are found significantly associated by applying sparse methods Lasso and SPLS \[[@B10],[@B11]\].

Methods
=======

Data
----

Both the real and simulated data that were made available for Genetic Analysis Workshop 18 (GAW18) were used. We focused on the genotype data on chromosome 3 for unrelated individuals. The baseline data for the covariates and the phenotypes were considered. We considered the first time point of systolic blood pressure (SBP) and diastolic blood pressure (DBP) as the traits. We also used a composite of the 2 phenotypes called the mean arterial pressure, which is defined as (2/3)\*DBP + (1/3)\*SBP. For the genotype data, we mapped single-nucleotide polymorphisms (SNPs) to the genes; the remaining SNPs that do not belong to any genes, were grouped as intergenic regions. A total of 2286 regions (consisting of 1224 genes and 1062 intergenic regions) that include all the SNPs were defined. The regions were further divided into \"rare\" or \"common\" based on minor allele frequency (MAF) threshold of 0.01.

Association tests
-----------------

TOW and VW-TOW are recently proposed methods that allow covariates and account for direction effects for causal variants. Let $Z_{i} = \left( {z_{i1},\ldots,z_{ip}} \right)^{T}$, $X_{i} = \left( {x_{i1},\ldots,x_{iM}} \right)^{T}$ and $y_{i}$ be the covariates, genotype (coded 0, 1, 2) and phenotype for the *i*^th^individual, where *p*and *M*denote number of covariates and variants, respectively. The effects of the covariates on $y_{i}$ and $x_{im}$ are adjusted by the residuals of the following linear models

$$y_{i} = \alpha_{0} + \alpha_{1}z_{i1} + \ldots + \alpha_{p}z_{ip} + \varepsilon_{i}$$

and

$$x_{im} = \alpha_{0m} + \alpha_{1m}z_{i1} + \ldots + \alpha_{pm}z_{ip} + \tau_{im}.$$

The methods are based on the optimal weighting scheme, which is defined as $w_{m}^{o} = \frac{\sum_{i = 1}^{n}\left( {ỹ_{i} - ỹ} \right)\left( {{\overset{\sim}{x}}_{im} - {\overset{\sim}{x}}_{m}} \right)}{\sum_{i = 1}^{n}\left( {{\overset{\sim}{x}}_{im} - {\overset{\sim}{x}}_{m}} \right)^{2}}$, where $ỹ_{i}$ and ${\overset{\sim}{x}}_{im}$ denote the residuals from equations (1) and (2) for the *i*^th^individual respectively. Let $x_{i}^{o} = \sum\limits_{m = 1}^{M}w_{m}^{o}{\overset{\sim}{x}}_{im}$. The test statistics for TOW is defined as $T_{TOW} = \sum\limits_{i = 1}^{n}\left( {ỹ_{i} - ỹ} \right)\left( {x_{i}^{o} - x^{o}} \right)$. For VW-TOW, let $T_{r}$ and $T_{c}$ denote the test statistics of TOW for rare and common variants, $T_{\lambda} = \lambda\frac{T_{r}}{\sqrt{var\left( T_{r} \right)}} + \left( {1 - \lambda} \right)\frac{T_{c}}{\sqrt{var\left( T_{c} \right)}}$ and $p_{\lambda}$ be the *p*value of $T_{\lambda}$. The test statistics for VW-TOW is defined as $T_{VW - TOW} = \text{min}_{0 \leq \lambda \leq 1}p_{\lambda} = \text{min}_{0 \leq \text{k} \leq \text{K}}p_{\lambda_{k}}$, where $\lambda_{k} = \text{k}/\text{K}$ for $\text{k} = 0,1,\cdots\;,\text{K}$. The *p*values are evaluated by permutation.

After identifying the significant genomic regions, we further investigated the SNPs that have important contribution to the phenotypes for the significant regions by variable selection methods Lasso and SPLS, which are available in the R package: \"RV tests.\" Because this package does not allow covariates, we adjusted the effect of environmental factors using the linear model shown in equation (1). Instead of the observed trait, the residuals from the linear model are treated as the phenotype.

A summary of the steps we followed for real data
------------------------------------------------

Step 1: Map the SNPs to gene and intergenic regions based on the annotation file refGene.txt.gz (available from <http://hgdownload.cse.ucsc.edu>/). Then the genes or intergenic regions were further divided into subregions (\"rare\" vs. \"common\") based on a threshold of MAF = 0.01.

Step 2: Extract the genotype, phenotype (baseline measures) and covariates (baseline measures) data for the unrelated individuals. Remove the participants that have missing variables in phenotype or covariates data.

Step 3: TOW and VW-TOW are applied to identify the regions that are associated with the traits.

Step 4: Apply Lasso and SPLS to the regions to discriminate the associated variants from noise (using the R package \"RV tests\").

Results
=======

Real data
---------

The sample used in our analysis is made up of 142 independent individuals. After removing missing variables, 129 subjects were analyzed. There are, in total, 1,215,296 markers on chromosome 3; approximately one-sixth of the markers were removed as a result of zero variation across the 129 independent samples.

The association tests (TOW and VW-TOW) were applied to each genetic region for SBP, DBP, and mean arterial pressure (MAP) on chromosome 3. Both tests produce an empirical *p*value, based on 10,000 permutations for each region. Figure [1](#F1){ref-type="fig"} displays the *p*value plot for DBP, where the x-axis denotes the position of the genes in original order on chromosome 3. The *p*values for intergenic regions are not included in Figure [1](#F1){ref-type="fig"}. By parallel comparison, we can see that effects of the genes are caused by the rare variants or the common variants. We note that there is a small cluster of genes that appear highly significant around the 440th region in the upper and lower plots.

![**p value plot for DBP (rare variants); p value plot for DBP (common variants); and p value plot for DBP (combined)**.](1753-6561-8-S1-S46-1){#F1}

After obtaining all the *p*values, regions that have strong association with the traits are picked according to the ranking of the *p*values. We decided to set the significant level threshold to be 0.001, so as to be more selective. Genes are only selected if they satisfy this criterion for the trait using both TOW and VW-TOW. Table [1](#T1){ref-type="table"} lists the regions that appear to be potentially important. For SBP, there are 3 genes; 2 genes with common variants only and 1 gene with rare variants only are highly associated with the trait. For MAP there are 4 genes when a combined analysis of \"rare\" and \"common\" variants is done, and 2 genes are significant with common variants only. For DBP, the number of significant regions is greater than the other 2 traits. For this trait, not only variants that belong to genes, but also variants in intergenic regions exhibit strong association.

###### 

Common, rare and total number of variants identified by LASSO, SPLS and by both methods.

                    Common variants        Rare variants        Combined variants                                                       
  ----- ----------- ----------------- ---- --------------- ---- ------------------- ----- ----- ---- ---- ----------- ----- ----- ----- ----
  SBP   LAMP3       167               28   21              2    TP63                485   109   94   31   LAMP3       267   18    21    2
                                                                                                                                        
        LIMD1       371               20   39              15                                             LIMD1       538   88    39    18
                                                                                                                                        
                                                                                                          RAP2B       15    1     1     1
                                                                                                                                        
  DBP   Inter-530   315               72   104             29   BAP1                24    7     8    7    BAP1        30    8     9     8
                                                                                                                                        
        CTDSPL      277               20   19              14   Inter-378           42    10    10   7    CCCDC66     373   42    57    20
                                                                                                                                        
        SLC25A36    88                7    6               6    Inter-896           23    4     8    4    Inter-376   10    1     2     1
                                                                                                                                        
                                                                Inter-898           55    8     14   8    Inter-377   41    5     8     4
                                                                                                                                        
                                                                CPB1                52    3     7    2    Inter-378   75    11    10    7
                                                                                                                                        
                                                                DNAH1               211   40    41   16   Inter-896   47    4     8     4
                                                                                                                                        
                                                                E1F5A2              34    11    5    5    Inter-982   206   27    2     2
                                                                                                                                        
                                                                GLYCTK              13    4     5    4    CPB1        164   18    9     5
                                                                                                                                        
                                                                NCBP2               24    2     2    2    DNAH1       326   114   43    31
                                                                                                                                        
                                                                SEMA3G              30    7     8    5    EIF5A2      77    19    5     5
                                                                                                                                        
                                                                TNNC1               7     3     4    3    GLYCTK      25    4     5     4
                                                                                                                                        
                                                                WDR82               36    11    12   10   PHF7        40    3     14    3
                                                                                                                                        
                                                                                                          PIGZ        115   5     6     5
                                                                                                                                        
                                                                                                          PPM1M       12    2     2     2
                                                                                                                                        
                                                                                                          SEMA3G      42    7     8     5
                                                                                                                                        
                                                                                                          TNNC1       10    3     4     3
                                                                                                                                        
                                                                                                          TWF2        50    10    10    9
                                                                                                                                        
                                                                                                          WDR82       73    11    12    10
                                                                                                                                        
  MAP   LAMP3       167               20   2               2                                              GP5         32    6     2     2
                                                                                                                                        
        LIMD1       371               10   51              5                                              LAMP3       267   3     2     2
                                                                                                                                        
                                                                                                          LIMD1       538   49    106   35
                                                                                                                                        
                                                                                                          RAP28       15    2     2     1

A, number of total variants; B, number of variants selected by LASSO; C, number of variants selected by SPLS; D, number of variants selected by both LASSO and SPLS; Inter-376, region between PPMIM & WDR82; Inter-377, region between WDR82 & GLYCTK; Inter-378, region between GLYCTK & DNAH1; Inter-530, region between NXPE3 & LOC152225; Inter-896, region between RPL22L1 & EIF5A2; Inter-898, region between SLC2A2 & TNIK; Inter-982, region between ST6GAL1 & RPL39L

As mentioned earlier, there is a cluster of regions (shown in Figure [1](#F1){ref-type="fig"}) that show strong significance for DBP. The region names are: TWF2, PPM1M, region between PPM1M and WDR82, WDR82, region between WDR82 and GLYC7K, GLYC7K, region between GLYC7K and DNAH1, BAP1, PHF7, SEMA3G, and TNNC1. The above regions all fall inside the physical location range of (52262625, 52488057).

Then variable selection methods Lasso and SPLS are applied to the regions that are picked at the gene (or region) level. Table [1](#T1){ref-type="table"} also summarizes the numbers of significant markers that were selected using these sparse methods. The number of selected markers can be varied with different choice of penalty parameter.

Simulated data
--------------

In stage I, we focused on the top significant genes on chromosome 3, which are MAP4, FLNB, and ABTB1, with common and rare variants combined. We analyzed all 200 replicates with the target genes to assess the power of TOW and VW-TOW. MAP4 has large effect on both SBP and DBP, whereas FLNB and ABTB1 have small effects on SBP only. We adjusted the phenotypes by all the covariates at baseline. Table [2](#T2){ref-type="table"} reports the results. We can see that both methods have very poor power when the variants are all rare in the genes. Table [2](#T2){ref-type="table"} does show, however, that TOW has better performance than VW-TOW in most cases. MAP shows better power than the other 2 phenotypes. In the cases of small effect size, the power is very low for both TOW and VW-TOW.

###### 

Power of TOW and VW-TOW to detect MAP4, FLNB, and ABTB1

                          Power (MAP4)   Power (FLNB)   Power (ABTB1)                   
  ----------------- ----- -------------- -------------- --------------- ------- ------- -------
  Gene (combined)   SBP   0.32           0.265          0.02            0.015   0.095   0.07
                    DBP   0.325          0.26                                           
                    MAP   0.435          0.35                                           
                                                                                        
  Gene (rare)       SBP   0.035          0.03           0.005           0.01    0.095   0.075
                    DBP   0.06           0.06                                           
                    MAP   0.05           0.045                                          
                                                                                        
  Gene (common)     SBP   0.335          0.29           0.03            0.045   0.08    0.075
                    DBP   0.345          0.245                                          
                    MAP   0.445          0.33                                           

In stage II, we assessed the performance of Lasso and SPLS by analyzing all 200 replicates on MAP4 with all the variants. There are 6 target SNPs in MAP4, but 1 of the SNPs is removed because of monomorphism. The location numbers of the 5 SNPs are 48040283, 47957996, 47956424, 48040284, and 47913455. Both Lasso and SPLS are variable selection methods. With the careful selection of the penalty parameters for both methods, on average approximately 5 variants are selected with every replicate. Table [3](#T3){ref-type="table"} shows the results. We can see that using MAP as phenotype demonstrates higher power than using SBP or DBP. Lasso and SPLS have very poor power to detect 47956424 and 47913455.

###### 

Power of Lasso and SPLS to select significant variants

                Power for each SNP(MAP4)                           
  ------- ----- -------------------------- ------- ------- ------- -------
  LASSO   SBP   0.53                       0.255   0       0.38    0.065
          DBP   0.5                        0.22    0       0.305   0.06
          MAP   0.705                      0.265   0       0.52    0.075
                                                                   
  SPLS    SBP   0.75                       0.545   0.015   0.215   0.015
          DBP   0.66                       0.43    0.01    0.185   0.03
          MAP   0.835                      0.66    0.005   0.265   0.025

Discussion
==========

Most recently proposed methods assign large weights to rare variants and small weights to common variants, resulting in low power. On the other hand, TOW and VW-TOW assign corresponding weight, which can account for the direction effect, to individual variants. The methods outperform some currently popular methods, such as Combined Multivariate and Collapsing (CMC) and sequence kernel association test (SKAT), in various scenarios \[[@B9]\]. In addition, both TOW and VW-TOW can be modified to account for population stratification using principal component approach.

Overall, we were able to detect some significant genes based on association tests (TOW and VW-TOW) with SBP, DBP, and MAP. Although we used Lasso and SPLS only as variant selection methods, they can also be used to do the association test for genotype with complex traits. However, both Lasso and SPLS are very computationally intensive. In addition, our analysis is focused on the independent subjects only, which limits our sample size. For future study, it is essential to incorporate family structure that not only increases the size of the sample available for analysis, but also the number of variants. Because SBP and DBP are correlated, it is deficient to analyze them separately. MAP, which is a combination of SBP and DBP, has better power than SBP and DBP separately.
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